Focused Wealth Management, Inc - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$0100.0%0.00%
Q1 2022$0
-100.0%
10
-99.5%
0.00%
-100.0%
Q4 2021$89,000
+8800.0%
2,010
+14257.1%
0.01%
Q3 2021$1,00014
+40.0%
0.00%
Q2 2021$0
-100.0%
10
-96.7%
0.00%
-100.0%
Q1 2018$12,000
-66.7%
300
-70.2%
0.00%
-66.7%
Q4 2017$36,000
-12.2%
1,0070.0%0.01%
-14.3%
Q3 2017$41,000
+36.7%
1,007
+42.4%
0.01%
+27.3%
Q2 2017$30,000
+3.4%
707
+1.3%
0.01%0.0%
Q1 2017$29,000
-3.3%
698
-11.6%
0.01%
-15.4%
Q4 2016$30,000
-11.8%
790
+1.0%
0.01%
-13.3%
Q3 2016$34,0000.0%782
+0.9%
0.02%
-6.2%
Q2 2016$34,000
-33.3%
775
-38.6%
0.02%
-42.9%
Q1 2016$51,000
-50.0%
1,262
-50.2%
0.03%
-52.5%
Q4 2015$102,000
+9.7%
2,535
+4.5%
0.06%0.0%
Q3 2015$93,000
-7.9%
2,426
+0.4%
0.06%
-4.8%
Q2 2015$101,000
+13.5%
2,417
+25.9%
0.06%
+12.7%
Q1 2015$89,000
+8.5%
1,920
+0.5%
0.06%
-5.2%
Q4 2014$82,000
-5.7%
1,911
+0.4%
0.06%
-13.4%
Q3 2014$87,000
-24.3%
1,903
-11.3%
0.07%
-25.6%
Q2 2014$115,000
+2.7%
2,146
+2.0%
0.09%
-4.3%
Q1 2014$112,0000.0%2,104
+0.3%
0.09%0.0%
Q4 2013$112,000
+6.7%
2,097
+0.3%
0.09%
-6.0%
Q3 2013$105,0002,0910.10%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2016
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders